IL1B and mucopolysaccharidosis type 3A: Furthermore, we have reported that both IL-1β and its receptor antagonist IL-1Ra are elevated in MPS IIIA patients and mouse models, as well as several other MPS diseases (Mandolfo et al, 2022).